Respiratory

Researchers have found that the COVID-19 pandemic has caused potentially millions of children to miss routine vaccines. During a time of back-to-school excitement and reversals of transmission prevention efforts in some states, children may be at risk of facing a slew of non-COVID-19 viral outbreaks.

The authors said the results may prove useful in adding to the relatively small body of information known about the relationship between health-related quality of life and how the severity of asthma affects a patient’s preference values.

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.

FDA halts sale of more than 50,000 flavored e-cigarette products; health systems in Idaho and Oregon struggle to meet the influx of patients with COVID-19; drop in breast cancer screening rates seen throughout pandemic.

Researchers conducted a literature survey about chronic cough symptoms to create a patient-reported outcome measurement (PROM) tool in order to measure cough severity.

Use of electronic nicotine products was associated with an increased likelihood of dry nighttime cough and wheezing in adolescents, according to findings gleaned from a large survey.

Patients with chronic cough reported autonomic symptoms with substantially increased frequency and severity when compared with a healthy control population.

Mortality risk stratification can identify patients with COVID-19 who are at higher risk of mortality, discharge to skilled nursing facility, and readmission, and may benefit from focused intervention strategies.

Survey data found that better diagnosis and treatment methods are needed among patients with chronic cough in Japan due to the prevalent nature of the condition.

A newly released internal CDC report shows the agency's communication struggles and its challenges in combatting the virulent delta variant, acknowledges the need for universal masking, and illustrates the effectiveness of vaccines in preventing more severe illness and death in those who are inoculated.

Patients may find a placebo effect beneficial, but it causes issues in a clinical trial and makes it difficult to understand the efficacy of a pharmacological agent, said Ron Eccles, BSc, PhD, DSc, emeritus professor at Cardiff University.

Many respiratory viruses demonstrated atypical activity levels as compared with previous rates of activity during pre-pandemic seasonality, the CDC said this week.

Patients with complex chronic cough reported high satisfactory levels with virtual consultations.

After years of having cough related to asthma, it took a long time for a specialist to realize Paulette Nyahay had a chronic cough unrelated to her asthma.

As COVID-19 cases skyrocketed in the United States throughout the pandemic, incidences of other respiratory viral infections dramatically declined.

Moderna starts testing for its new mRNA seasonal flu vaccine; the worldwide COVID-19 death toll hits 4 million as Delta variant spreads; more states sign on to Purdue Pharma's bankruptcy reorganization plans after additional payments and release of documents are added to the deal.

Patients with a cough lasting more than 8 weeks are diagnosed with chronic cough, and for a subpopulation of those patients there is no treatable underlying cause of their cough, said Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center.

Not all asthma is created equal, nor will all therapies work for all patients. With continued innovations in asthma treatments offering new, improved options for patients, we are more prepared than ever to address uncontrolled asthma head-on.

Patients with a chronic cough that persists even after treatment usually see a few specialists and have lingering triggers that cause their cough, explained Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.

A recent study said superior laryngeal nerve (SLN) blocks are effective for treating neurogenic cough, which are coughs that continue and persist after other conditions are ruled out.

Stephanie Lovinsky-Desir, MD, MS, discusses the need for concrete changes addressing social determinants of health (SDOH) and respiratory health.

Fernando Holguin, MD, explains why increased risk of pulmonary disease may be overlooked when assessing obesity risk factors.

Chronic cough makes it difficult to be in public, whether socially or professionally, explained Paulette Nyahay, a patient with chronic cough. Especially during the COVID-19 pandemic, having a coughing spasm in public has been difficult.

Understanding why this difference exists could assist with finding new therapies, said the authors.

Farrah Kheradmand, MD, elaborates on the effects of marijuana legalization and increased recreational use on research into electronic cigarettes.

If 2020 was dominated by the news of how COVID-19 spread across the globe, then 2021 has so far been focused on ending the pandemic through vaccine distribution.

Nicotine replacement therapy can help with smoking cessation, but there are dangers of using e-cigarettes, said Laura Crotty Alexander, MD, ATSF.

Patients with post–COVID-19 symptoms for at least 4 weeks should be assessed for pulmonary, cardiac, neurocognitive, and psychiatric complications and referred to a specialized clinic, a recent study notes

Michelle M Cloutier, MD, is professor emerita at UCONN Health in Farmington, Connecticut, and chair of the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee Expert Panel Working Group.

Joe Zein, MD, PhD, from Cleveland Clinic, explains factors apart from sex and age that can have an impact on a patient's asthma.